摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Quinazolin-2-ylmethanol | 2091895-09-7

中文名称
——
中文别名
——
英文名称
Quinazolin-2-ylmethanol
英文别名
——
Quinazolin-2-ylmethanol化学式
CAS
2091895-09-7
化学式
C9H8N2O
mdl
——
分子量
160.175
InChiKey
YTNBLSVLSJYVLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    46
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    Quinazolin-2-ylmethanol盐酸4-二甲氨基吡啶N,N'-二环己基碳二亚胺 作用下, 以 二氯甲烷乙酸乙酯 为溶剂, 反应 5.0h, 生成
    参考文献:
    名称:
    Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)
    摘要:
    Novel L-valinate amide benzoxaboroles and analogues were designed and synthesized for a structure-activity-relationship (SAR) investigation to optimize the growth inhibitory activity against Trypanosoma congolense (T. congolense) and Trypanosoma vivax (T. vivax) parasites. The study identified 4-fluorobenzyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2] oxaborole-6-carbonyl)-L-valinate (5, AN11736), which showed IC50 values of 0.15 nM against T. congolense and 1.3 nM against T. vivax, and demonstrated 100% efficacy with a single dose of 10 mg/kg against both T. congolense and T. vivax in mouse models of infection (IP dosing) and in the target animal, cattle, dosed intramuscularly. AN11736 has been advanced to early development studies. (C) 2017 The Authors. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2017.11.028
点击查看最新优质反应信息

文献信息

  • EP1385833A1
    申请人:——
    公开号:EP1385833A1
    公开(公告)日:2004-02-04
  • [EN] TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS<br/>[FR] DERIVES D'AMIDE DE TRIAZINYLE UTILES EN TANT QU'INHIBITEURS DE ANGIOGENESE
    申请人:AMGEN INC
    公开号:WO2002083654A1
    公开(公告)日:2002-10-24
    The invention encompasses compounds of formula (I), analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical composition, uses and methods for prophylaxis and treatment of cancer and angiogenesis-related disease.
查看更多